David Tierney

David S.
Tierney was the founder of Oceana Therapeutics, Inc., founded in 2008, where the titles held included President, Chief Operating Officer & Director in 2011.
Current jobs include President, CEO, Secretary, Treasurer & Director at Aramis Biosciences, Inc., and Director at Bimeda, Inc. since 2018.
Former jobs include President, Chief Executive Officer & Director at Valera Pharmaceuticals, Inc. from 2000 to 2007; President & Chief Executive Officer at Icon Bioscience, Inc. from 2014 to 2018; Chief Executive Officer at Pharma Two B Ltd. from 2020 to 2021; President & Chief Executive Officer at BioPharmX Corp.
from 2019 to 2020; Director at Bioject Medical Technologies, Inc.; Director at Able Laboratories, Inc.; Director at Apricus Biosciences, Inc. from 2007 to 2009; Medical Director at Elan Pharmaceuticals LLC from 1989 to 1997; Director at Viatar CTC Solutions, Inc.; Director at Palvella Therapeutics, Inc.; Independent Director at Zevra Therapeutics, Inc.; Independent Director at Catalyst Pharmaceuticals, Inc. from 2011 to 2026; Senior Vice President-Drug Development at Roberts Pharmaceutical Corp.
from 1997 to 2000; Venture Partner at Signet Healthcare Partners LLC from 2013 to 2014; and President at Biovail Technologies Ltd. in 2000.
Education includes a doctorate conferred in 1987 from the Royal College of Surgeons.